Atezolizumab-induced Encephalitis in a Patient with Hepatocellular Carcinoma: A Case Report and Literature Review-Reference-Cited by-同舟云学术

Atezolizumab-induced Encephalitis in a Patient with Hepatocellular Carcinoma: A Case Report and Literature Review

Published:2022-09-01 Issue:17 Volume:61 Page:2619-2623
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Satake Tomoyuki¹,Maruki Yuta¹,Kubo Yuko²,Takahashi Masamichi³,Ohba Akihiro¹,Nagashio Yoshikuni¹,Kondo Shunsuke¹,Hijioka Susumu¹,Morizane Chigusa¹,Ueno Hideki¹,Okusaka Takuji¹

Affiliation:

1. Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Japan

2. Department of Diagnostic Radiology, National Cancer Center Hospital, Japan

3. Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/61/17/61_8919-21/_pdf

Reference21 articles.

1. 1. Kao JC, Liao B, Markovic SN, et al. Neurological complications associated with anti-programmed death 1 (PD-1) antibodies. JAMA Neurol 74: 1216-1222, 2017.

2. 2. Kim A, Keam B, Cheun H, et al. Immune-checkpoint-inhibitor-induced severe autoimmune encephalitis treated by steroid and intravenous immunoglobulin. J Clin Neurol 15: 259-261, 2019.

3. 3. Williams TJ, Benavides DR, Patrice KA, et al. Association of autoimmune encephalitis with combined immune checkpoint inhibitor treatment for metastatic cancer. JAMA Neurol 73: 928-933, 2016.

4. 4. Rittmeyer A, Barlesi F, Waterkamp D, et al.; OAK Study Group. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial. Lancet 389: 255-265, 2017.

5. 5. Socinski MA, Jotte RM, Cappuzzo F, et al. IMpower150 study group. Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC. N Engl J Med 14: 2288-2301, 2018.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atezolizumab- and bevacizumab -induced encephalitis in a patient with advanced hepatocellular carcinoma: a case report and literature review;Journal of Cancer Research and Clinical Oncology;2024-08-24

2. Atezolizumab- and bevacizumab -induced encephalitis in a patient with advanced hepatocellular carcinoma: a case report and literature review;2024-07-19

3. Systemic therapies in hepatocellular carcinoma: A revolution?;United European Gastroenterology Journal;2024-01-24

4. A Case of Patient with Atezolizumab-induced Encephalitis in Hepatocellular Carcinoma;Internal Medicine;2024

5. Atezolizumab-induced encephalitis with subdural hemorrhage and subarachnoid hemorrhage in a patient with hepatocellular carcinoma;Journal of the Formosan Medical Association;2023-11